XFOR
NASDAQ · Biotechnology
X4 Pharmaceuticals Inc
$4.19
+0.12 (+2.95%)
Open$4.05
Previous Close$4.07
Day High$4.24
Day Low$4.05
52W High$4.83
52W Low$1.35
Volume—
Avg Volume356.8K
Market Cap393.21M
P/E Ratio—
EPS$-4.38
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+578.3% upside
Current
$4.19
$4.19
Target
$28.42
$28.42
$21.41
$28.42 avg
$38.37
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 77.91M | 38.69M | 57.05M |
| Net Income | -175,732,649 | -510,081,137 | 9.29M |
| Profit Margin | -225.6% | -1,391.4% | 16.3% |
| EBITDA | -163,270,139 | -479,400,827 | 17.50M |
| Free Cash Flow | — | — | 7.43M |
| Rev Growth | — | -5.2% | +3.4% |
| Debt/Equity | 0.41 | 3.41 | 0.94 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |